Beyond TNF Blockade: Breakthroughs in Rheumatoid Arthritis Pathogene…

John Tesser

CVD in RA: Need for Management of CVD in RA, CV Risk Calculation & M…

Cleveland Clinic Department of Rheumatic and Immunologic Disease

W. Rigby

RA: Use of Imaging to Predict Transition to RA, the Changing Landsca…

Cleveland Clinic Department of Rheumatic and Immunologic Disease

W. Rigby

Red Eye in RA: What Is the Differential Diagnosis in General and in …

Cleveland Clinic Department of Rheumatic and Immunologic Disease

J. Rosenbaum

Interstitial Lung Disease Update: Should We Treat Asymptomatic ILD? …

Cleveland Clinic Department of Rheumatic and Immunologic Disease

J. Parambil

Interstitial Lung Disease: What Are the Most Important Advances in C…

Cleveland Clinic Department of Rheumatic and Immunologic Disease

J. Parambil

Connective Tissue Disease-Associated Interstitial Lung Disease: Why …

Cleveland Clinic Department of Rheumatic and Immunologic Disease

J. Parambil

Tapering vs. Continuing Glucocorticoids in RA: Do Autoantibody Level…

Cleveland Clinic Rheumatology

A. Kavanaugh, J. Cush

bDMARDs and nbDMARDs in RA: Is VTE a Clinical Concern in RA?

Cleveland Clinic Rheumatology

A. Kavanaugh, J. Cush

Rheumatic Diseases & JAKi Efficacy Results: Is TYK2 Effective in PsA…

Cleveland Clinic Department of Rheumatic and Immunologic Disease

A. Kavanaugh, J. Cush

RA & 8 TNFi Biosimilars Efficacy Analysis: Can Multiple bDMARD Switc…

Cleveland Clinic Department of Rheumatic and Immunologic Disease

A. Kavanaugh, J. Cush

bDMARDS in RA: Why Do Patients With Low Levels of 1st TNFi Respond B…

Cleveland Clinic Rheumatology

A. Kavanaugh, J. Cush

Refractory Pain in Early RA: What Are the Alternative Treatment Stra…

Cleveland Clinic Rheumatology

A. Kavanaugh, J. Cush

IMIDs & Vaccines Update: What Are the Updated Immunization Recommend…

Cleveland Clinic Department of Rheumatic and Immunologic Disease

C. Calabrese

Rheumatology – Oncology: Cases with the Masters

Cleveland Clinic Department of Rheumatic and Immunologic Disease

L. Calabrese, V. Velcheti

T Cell Subsets Overview: Is TH1 Critically Important for Killing Fac…

Cleveland Clinic Rheumatology

J. Looney

Links Between Chronic Inflammation and Atherosclerotic Disease and E…

Cleveland Clinic Rheumatology

E. Husni

Cardiovascular Risk on RA and PsA Patients: What are the Most Common…

Cleveland Clinic Rheumatology

E. Husni

Human Behavior and Immunity – Slowing Aging?

Cleveland Clinic Rheumatology

L. Calabrese

Management of Rheumatic irAEs: Is ICI Therapy Safe For Patients With…

Cleveland Clinic Rheumatology

C. Calabrese

Immune Related Adverse Events from Cancer Immunotherapy: The Role of…

Cleveland Clinic Department of Rheumatic and Immunologic Disease

C. Calabrese

Cases with the Masters Discussion: Vasculitis, Co-morbidities, Rheum…

Cleveland Clinic Rheumatology

J. Looney, C. Calabrese

Case Review of 40-Year-Old Male HIV-infected Patient With Severe Pol…

Cleveland Clinic Rheumatology

J. Looney, C. Calabrese

Cases with the Masters: Clinical Challenges in Rheumatoid Arthritis

Cleveland Clinic Rheumatology

L. Calabrese, E. Keystone, A. Kavanaugh, I. Mcinnes, J. Kay, J. Cush

Targeting the IL1 Family in Autoimmune and Autoinflammatory Diseases

Cleveland Clinic Rheumatology

J. Looney

Biologics Across Immune-Mediated Inflammatory Diseases from the Rheu…

Cleveland Clinic Medical Specialty Institute

A. Kavanaugh, J. Cush

Predicting Outcomes in RA - The Role of Biomarkers

Cleveland Clinic Department of Rheumatic and Immunologic Disease

J. Kay

Pre-Rheumatoid Arthritis: Can We Define It and Prevent Its Progressi…

Cleveland Clinic Department of Rheumatic and Immunologic Disease

M. Holers

Cytokine Profiles in Health and Disease

Cleveland Clinic Department of Rheumatic and Immunologic Disease

I. Mcinnes

Increased Inflammation and Disease Activity Among Current Cigarette …

Cleveland Clinic Rheumatology

T. Mikuls

IgA Plasmablasts Are Evaluated in Subjects at Risk for Future Rheuma…

Cleveland Clinic Department of Rheumatic and Immunologic Disease

L. Calabrese, M. Holers

Advances in Rheumatoid Arthritis

Cleveland Clinic Rheumatology

W. Rigby

PPACMAN Update (Rheumatology/Dermatology)

Cleveland Clinic Department of Rheumatic and Immunologic Disease

J. Merola

Preventing Infections in Patients Treated with Biologics

Cleveland Clinic Department of Rheumatic and Immunologic Disease

C. Calabrese

Revisiting Anti-TNF 20 Years Later

Cleveland Clinic Department of Rheumatic and Immunologic Disease

J. Looney

T-Cell and B-Cell (and Other) Targeting in IMIDs

Cleveland Clinic Department of Rheumatic and Immunologic Disease

G. Silverman

IL6 Targeting

Cleveland Clinic Department of Rheumatic and Immunologic Disease

L. Calabrese

Tailoring Therapy Based on Disease Duration: Is There A Window of Op…

Cleveland Clinic Department of Rheumatic and Immunologic Disease

E. Keystone

Predicting the Outcome of Treatment De-Escalation or Discontinuation…

Cleveland Clinic Department of Rheumatic and Immunologic Disease

A. Kavanaugh

Herpes Zoster and the Risk of Stroke in Patients with Autoimmune Dis…

Cleveland Clinic Department of Rheumatic and Immunologic Disease

L. Calabrese, C. Calabrese

Why Personal Behavior Affects Immune Mediated Inflammatory Diseases

Cleveland Clinic Department of Rheumatic and Immunologic Disease

L. Calabrese

Anti-Drug Antibodies, Random Drug Levels with Efficacy in Certolizum…

Cleveland Clinic Rheumatology

L. Calabrese, M. Jani